Validation of the AJCC Prognostic Stage for HER2-positive Breast Cancer in the ShortHER Trial
BMC Medicine - United Kingdom
doi 10.1186/s12916-019-1445-z
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 21, 2019
Authors
Publisher
Springer Science and Business Media LLC